ADO anticorps (C-Term)
Aperçu rapide pour ADO anticorps (C-Term) (ABIN950285)
Antigène
Voir toutes ADO AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 206-233, C-Term
-
Specificité
- This antibody reacts to ADO.
-
Réactivité croisée (Details)
- Species reactivity (tested):Human and Mouse.
-
Purification
- Affinity chromatography on Protein A
-
Immunogène
- KLH conjugated synthetic peptide between 206-233 amino acids from the C-terminal region of human ADO
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) sodium azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ADO (2-Aminoethanethiol (Cysteamine) Dioxygenase (ADO))
-
Autre désignation
- ADO
-
Sujet
- Human thiol dioxygenases include cysteine dioxygenase (CDO, MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO, EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine (Dominy et al., 2007).Synonyms: 2-aminoethanethiol dioxygenase, C10orf22, Cysteamine dioxygenase
-
ID gène
- 84890
-
NCBI Accession
- NP_116193
Antigène
-